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Abstract
Co-infections with HIV and HCV are very frequent among people who inject drugs (PWID).
However, very few studies comparatively reconstructed the transmission patterns of both
viruses in the same population. We have recruited 117 co-infected PWID during a recent
HIV outbreak in Romania. Phylogenetic analyses were performed on HIV and HCV seq-
uences in order to characterize and compare transmission dynamics of the two viruses.
Three large HIV clusters (2 subtype F1 and one CRF14_BG) and thirteen smaller HCV
transmission networks (genotypes 1a, 1b, 3a, 4a and 4d) were identified. Eighty (65%)
patients were both in HIV and HCV transmission chains and 70 of those shared the same
HIV and HCV cluster with at least one other patient. Molecular clock analysis indicated that
all identified HIV clusters originated around 2006, while the origin of the different HCV clus-
ters ranged between 1980 (genotype 1b) and 2011 (genotypes 3a and 4d). HCV infection
preceded HIV infection in 80.3% of cases. Coincidental transmission of HIV and HCV was
estimated to be rather low (19.65%) and associated with an outbreak among PWID during
detention in the same penitentiary. This study has reconstructed and compared the disper-
sion of these two viruses in a PWID population.
Introduction
The use of contaminated needles is an effective way of spreading HIV; it accounts for 10% of
infections worldwide and for more than 40% in some regions and countries (Eastern Europe,
South America, and East and Southeast Asia) [1, 2]. Seroprevalence of HCV antibodies is very
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frequent among people who inject drugs (PWID) rising up to 90%; in the general HIV infected
population it raises only to about 10% [3–5]. HIV-HCV co-infection affects the natural history
of both diseases: increased mortality risk, increased AIDS and liver-related disease mortality,
accelerated hepatic fibrosis that leads to cirrhosis and/or hepatocellular carcinoma [6].
Both viruses have a high level of genetic diversity within and between hosts and a high rate
of evolution. For HIV-1, several groups, subtypes and circulating recombinant forms (CRFs)
are described; for HCV seven different genotypes have been described and each genotype has
distinct subtypes [7, 8]. The high evolutionary rate allows us to study the transmission history
of both viruses by analysing their genomic sequences with phylogenetic methods.
In recent years, an important HIV outbreak was reported among PWID in Romania, with
30.6% of the total newly diagnosed HIV cases in the country in 2012 [9]. The most affected
region was Bucharest and its suburbs where more than 90% of Romanian PWID are living
[10]. The Romanian PWID infected with HIV are mainly young males, unemployed, often
diagnosed in penitentiary, who inject both heroin and new psychoactive drugs („legal highs”),
and are frequently co-infected with HCV. Two predominant HIV strains were identified in
PWID: subtype F1 which had already been circulating in sexual and nosocomially infected
patients and the newly endemic CRF14_BG, most probably originating in Spain or Portugal
[11, 12].
Previous studies established the role of phylogenetic analysis in assessing and characterizing
transmission networks within particular populations, but these were mainly performed in spe-
cific populations of HIV patients. However, few studies have been performed that reconstruct
simultaneously the transmission history of HIV and HCV viruses in the same population of
HIV-HCV co-infected patients [13, 14] and none analysed the overlap between HIV and HCV
transmission networks. Our objective was to reconstruct the history and the transmission pat-
terns of HIV and HCV, to assess the likelihood of simultaneous transmission of these two




We have included in this study a number of 117 injecting drug users who were diagnosed with
HIV infection between 2011 and 2014 in the National Institute for Infectious Diseases ‘Matei
Bals’, the reference center for HIV genotyping. All patients were HCV co-infected and naive to
antiretroviral treatment. A number of 35 non-PWID, HCV mono-infected patients, were also
included in the study.
Blood samples and clinical and epidemiological data were collected through a questionnaire
survey. Laboratory testing (i.e. HIV viral load, CD4 count, HCV serology, HCV viral load) was
performed with in vitro diagnostic (IVD) tests.
Ethics statement
The study was conducted according to the Declaration of Helsinki and approved by the Ethical
Committee of the National Institute for Infectious Diseases ‘Matei Bals’. All the subjects
included in this study were adults who provided their written informed consent.
HIV genotyping
Total viral RNA was extracted from 1 ml of plasma using the automated NucliSens Easy-
MAG nucleic acid extraction system (BioMerieux, Marcy-l’E´toile, France), according to the
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manufacturer’s instructions and eluted in 25μl of water. Ten microliters of RNA were used
for HIV genotyping. Reverse transcription and amplification of the HIV-1 pol gene (1301
nucleotides, HXB2: 2253–3554) were performed using the Viroseq HIV-1 Genotyping Sys-
tem (Celera Diagnostics, Alameda, CA) and sequenced with the ABI 3500 Genetic Analyzer
(Applied Biosystems, Foster City, CA). The primary data were analysed using Sequencing
Analysis Software Version 3.7 (Life Technologies) and the generated sequences were assem-
bled with ViroSeq 2.8 HIV-1 Genotyping System Software (Celera Diagnostics, Alameda,
CA). REGA HIV-1&2 automated subtyping tool version 3.0 was used to assign the HIV-1
subtype [15]. Unclassified samples were further analysed in order to identify possible re-
combination breakpoints using Simplot v3.5.1 software and the Los Alamos HIV-1 subtype
reference dataset (sliding window: 400-nt, T:t ratio = 2.0, model of evolution: Kimura two-
parameter, bootstrap: 1000 replicates). All sequences were screened for hypermutation
using the Hypermut 2.0 algorithm [16].
HCV genotyping
Following RNA extraction as reported above, the NS5b and NS3 regions were sequenced for
HCV genotyping. Ten microliters of extracted viral RNA were used for reverse transcription
with Transcriptor Reverse Transcriptase (Roche) and random primers (Roche). For amplify-
ing the NS5b region (374 nucleotides, H77: 8256–8630), 1,1X Platinum PCR SuperMix (Life
Technologies) and previously published primers were used [17]. Different sets of primers, spe-
cifically designed for genotype 1, 2, 3a, 3b and 4 and 1,1X Platinum PCR SuperMix (Life Tech-
nologies) were used to amplify the first part of the NS3 gene (710 nucleotides, H77:3326–4036)
[18].
The NS5b and NS3 amplicons were bidirectionally sequenced using BigDye1 Terminator
system v 1.1 (Life Technologies) and ABI 3500 Genetic Analyzer (Applied Biosystems). Seqs-
cape version 2.7 (Applied Biosystems) was used to assemble and generate consensus sequences.
Genotyping was done using the publicly available algorithm Oxford HCV Automated Subtyp-
ing Tool (Version 2.0) [19].
Phylogenetic, phylodynamic analysis and divergence times of
transmission networks
Reference sequences were selected from public databases [20, 21] taking into account genotype
/ subtype, genomic region and geographic origin. To retrieve control sequences for transmis-
sion cluster reconstruction, the most similar HIV sequences were retrieved from our and Los
Alamos database using BLAST. Duplicates and clones were discarded. Of 421 selected control
sequences, those representative to geographical and time dispersion of the patients sample,
were subsequently used for each analysis. Controls for all the HIV-1 subtypes and CRFs identi-
fied among Romanian PWID were selected as follows: CRF14_BG (Spain, Portugal, Romania),
subtype F1 (Angola, Romania), subtype B (European countries), CRF35_AD (Afghanistan,
Iran). CRF14BG epidemics from Spain-Portugal [11] and Greece [12] were previously linked
to the Romanian HIV epidemic among PWID. Subtype F1 strains from Romanian PWID
were previously shown [11] to originate from strains already circulating in Romania and for-
merly described as related with strains from Angola [22, 23].
A similar procedure was used for the HCV dataset, where a number of 304 control seq-
uences were used. Multiple alignments were generated using Muscle [24].When available,
concatenate alignments of NS5b and NS3 sequences were used in the Bayesian analyses.
Phylogenetic analyses were performed using both maximum-likelihood (ML) and Bayesian
approaches, after selecting the best-fit nucleotide substitution model using JModelTest (GTR
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+4Γ+I for HIV-1 and TN93 for HCV). Datasets for each HIV-1 subtype and HCV genotype
identified among Romanian PWID were constructed and analyzed separately. ML trees were
inferred using FastTree software [25] and Bayesian phylogenetic analyses were performed with
BEAST version 1.8.1 [26] using a Bayesian Skyline coalescent tree prior [27] and the uncorre-
lated lognormal relaxed clock model [28]. Two Markov Chain Monte Carlo (MCMC) runs
were computed separately for 107 generations with a burn-in of 10%. The output of the
MCMC analysis was tested for convergence by means of effective sampling size (ESS>100)
using the program Tracer v1.6 [29]. The maximum clade credibility (MCC) tree was summa-
rized with TreeAnnotator program [30].
Transmission clusters were identified as clusters in the ML phylogenetic tree with SH-like
support higher or equal to 0.9 and were further confirmed with Bayesian phylogenetic analyses
if supported by a Bayesian posterior probability value of 1.0 [31, 32]. The temporal signal of
both datasets was evaluated with TempEst [33]. Data were statistically evaluated and plotted
using GraphPad Prism v6.0. The Mann-Whitney test was performed to identify differences
between groups and the Chi-square or Fisher exact test were used to evaluate the distribution
in particular subgroups; p-values <0.05 were considered significant.
Results
Characteristics of the population
The population of 117 co-infected PWID included in this study were diagnosed with HIV
between 2011 and 2014. The diagnosis of HCV and HIV was simultaneous for 71 patients
(60.7%), while for the remaining 46 individuals HCV diagnosis was established earlier than the
HIV diagnosis. Most of the PWID (64.1%, 75) were asymptomatic at the HIV diagnosis, while
35.9% were diagnosed in more advanced HIV infection stages, classified as stage B (27%, 32)
and C (9%, 10) according to CDC and WHO Staging Systems [34]. The 35 control HCV
mono-infected patients were diagnosed during the same period of time, also in the National
Institute for Infectious Diseases ‘Matei Bals’.
Disease severity differs when comparing patients infected with HIV-1
subtype F1 and with CRF14_BG-like strains
HIV-1 subtype analysis showed that 67.5% (n = 79) of the patients were infected with subtype F1
viruses; recombinant forms present in a significant proportion (26%; n = 30) were CRF14_BG
(n = 19, 16.24%) and unique recombinant forms (URF) of CRF_14BG and F1 (n = 11, 9.4%).
The PWID infected with these recombinant forms had significantly lower CD4 counts at base-
line than patients infected with subtype F1 strains. It is true, though, that an estimation of the
time to the infecting event was not possible in either case. No significant differences between
these two groups were observed when HIV viral load (VL) or CDC stages were analysed (Fig 1).
However, a higher percentage of patients infected with CRF14_BG were diagnosed at stages B
and C than the group infected with F1 (47% vs. 34%). Few patients (n = 8, 6.8%) were infected
with other types of HIV: subtype B, CRF35_AD and URFs between subtype A1 or B and F1
(Table 1).
HCV viral loads are higher in patients with HIV co-infection
All 117 patients were tested to assess the HCV genotype by analysing NS5b and/or NS3 regions
of HCV. Both NS5b and NS3 sequences were available for 110 patients, while for the remain-
ing patients only the NS5b region was available. The genotype assessment indicated that the
majority of PWID were infected with genotype 1a (n = 47, 40%) and 1b (n = 40, 34%), but
HIV and HCV transmission patterns in Romanian PWID
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genotypes 3a and 4 (a, d) were also identified (Table 1). HCV subtype assignment was concor-
dant in the two genomic regions in the majority of cases (n = 108, 98.2%), with only two excep-
tions of genotype 1 sequences (2749bh2013 and 2727bh2013) assigned as 1a in NS3 and 1b in
NS5b. Unlike HIV-HCV co-infected PWID, the individuals in the HCV mono-infected group
were exclusively infected with genotype 1b strains. Significant differences (Fig 1) in HCV VL
Fig 1. Clinical and laboratory characteristics of studied patients. A. Differences in HIV-VL among PWID, the two groups infected
with F1 subtype and recombinant forms (CRF14_BG, URFs of CRF14_BG and F1) B. Differences in HCV-VL in mono-infected and
HIV co-infected patients (PWID) C. CD4 count distribution in PWID at baseline D. Clinical HIV stages at diagnosis in PWID.
https://doi.org/10.1371/journal.pone.0185866.g001
Table 1. Distribution of HIV subtypes and HCV genotypes in Romania co-infected PWID. Chi-square analysis was performed on 2x3 contingency table
with pure HIV subtype /recombinant forms and HCV genotype 1a/1b/other and showed no significant difference in HIV subtype and HCV genotype distribution
(p = 0.784).
HIV subtypes HCV genotypes Total
1a 1b 3a 4a 4d
Subtype F1 30 29 9 6 5 79
Subtype B 3 1 0 0 0 4
CRF14_BG 7 8 2 0 2 19
CRF35_AD 1 0 0 0 0 1
Recombinants CRF14_BG and F1 5 2 2 1 1 11
Other recombinants 2 0 1 0 0 3
Total 48 40 14 7 8 117
https://doi.org/10.1371/journal.pone.0185866.t001
HIV and HCV transmission patterns in Romanian PWID
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were observed when comparing mono-infected with co-infected patients, with higher viral
loads in the group of co-infected.
All identified HIV clusters are large and originated around 10 years ago
Phylogenetic analysis of Romanian PWID using control sequences from Romania and other
parts of the world showed that 90 HIV sequences (76.9%) were part of well-supported phyloge-
netic clusters, suggesting high levels of transmission networking. Three major HIV local trans-
mission networks were identified by phylogenetic analysis, two within subtype F1 and one
with CRF14_BG (Fig 2). One of the subtype F1 clusters included 29 PWID patients, 24 men
Fig 2. Phylogenetic analysis of HIV-1 Romanian PWID sequences. Circular tree: Maximum likelihood tree generated as described
under Methods section. The sequences corresponding to PWID are colored in red and in black the control sequences. Rectangular trees:
The transmission networks identified in PWID were further confirmed with Bayesian phylogenetic analyses. Molecular clock analyses were
performed separately for F1 subtype and CRF14_BG sequences. In F1 subtype tree, in red are marked the PWID sequences, in blue are
represented sequences of sexually infected patients from Romania and in black are marked F1 sequences from Angola. In CRF14_BG
tree, the PWID sequences in red are marked and in green the sequences from Spain and Portugal (PWID). Different clusters were
highlighted on the trees and tMRCA was specifically marked for each cluster. The posterior probability support for each transmission cluster
is represented at the internal nodes. The scale is in years.
https://doi.org/10.1371/journal.pone.0185866.g002
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and 5 women; 17 men (58%) were diagnosed in the same penitentiary. The other subtype F1
cluster identified in PWID is larger and consists of 44 sequences corresponding to 34 men and
10 women living in the same geographical area. The lineages of both F1 clusters seem to origi-
nate from strains previously identified in Romanian people living with HIV (PLWH). The
transmission network identified in PWID infected with CRF14_BG involved 17 subjects, diag-
nosed with low CD4 counts (mean 138 cells/mm). The CD4 counts were significantly lower
than in patients from the two F1 transmission networks (mean CD4 count of cluster 1–430
cells/mm, cluster 2–510 cells/mm, p<0.001).
Phylodynamic analysis for all three HIV transmission networks among PWID indicated
similar starting time points, dating back to around 10 years ago (2006–2009, widest %95 HPD:
2001–2010). The results are in concordance with the epidemiological and seroconversion data
available from these patients.
HCV transmission clusters are smaller and their origins are more
dispersed in time
Phylogenetic reconstructions uncovered several HCV transmission clusters presented in Fig 3.
As opposed to HIV where the virus has spread in only three large clusters, HCV dispersion
occurred through multiple transmission networks. In total, 97 HCV sequences (82.9%) clus-
tered in 13 transmission clusters. In comparison, within the HCV mono-infected control
group only 8 out of 33 (24.2%) HCV sequences were found to form phylogenetic clusters
(χ2 = 42.18, p<0.001).
Four well supported clusters of different sizes were observed in both genotypes 1a and 1b;
the largest consisted of 23 sequences (genotype 1a) and 13 sequences (genotype 1b) (Table 2).
Three small genotype 3a clusters were observed, while genotype 4a and 4d sequences identified
among PWID formed each one single well supported cluster (Fig 3).
Molecular clock analysis of HCV transmission clusters revealed important differences in
origin and starting time points. The differences in divergence time were observed within as
well as among genotypes. Based on relaxed clock and constant size population model imple-
mented in a Bayesian MCMC framework, the oldest PWID network belongs to genotype 1b
and originated around 1983 (95%HPD: 1968–1994), followed by the larger HCV genotype 1a
cluster, dated back to 1987 (Figs 3 and 4). However, the time to the most recent common
ancestor (tMRCA) estimated for a sub-group of this 1a cluster consisting in 22 out of 23
sequences was more recent (2004, 95%HPD 1999–2006).
Genotype 1b was found to be the first introduced in the studied population: the oldest clus-
ter was estimated to be 30 years old in PWID and more than 50 years in non-PWID. Geno-
types 3 and 4 are the most recently introduced in this risk group population, dating back 2–3
years before sampling. The divergence times for all important PWID networks, HIV and
HCV, are presented in Table 2 and graphically illustrated in Fig 4.
Coincidental transmission of HIV and HCV is uncommon and occurred in
19.65% of the patients
We have comparatively analysed the patterns of patients distribution in HIV and HCV trans-
mission clusters (Fig 5). Eighty patients were present both in HCV and in HIV transmission
clusters (68.4% of all co-infected patients; 82.5% and 88.9% of all HCV and HIV patients pres-
ent in clusters, respectively). Furthermore, 70 patients (59.8%) were present in the same HIV
and HCV cluster with at least one other patient, indicating transmission of HIV and HCV
through (at least partly) overlapping transmission chains.
HIV and HCV transmission patterns in Romanian PWID
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Phylogenetic analysis and, in particular, measuring the difference in divergence times
between viral lineages within a co-infected individual has been proven useful in assessing the
frequency of viral coincidental transmission in PWID in the absence of seroconversion data
[35]. We have used the calculated difference of mean divergence times (ΔtMRCA) between
HIV and HCV lineages within a patient to estimate the time period lapsed between the acquisi-
tion of the two viruses. Low ΔtMRCA indicates a higher likelihood that the two viruses might
have been co-transmitted to a susceptible individual, while higher values of ΔtMRCA suggest
that the viruses were transmitted at different and distinct time points.
Fig 3. Phylogenetic analysis of HCV sequences in Romanian HIV co-infected PWID. Circular tree: Maximum likelihood tree generated as
described under Methods section. The sequences corresponding to PWID are colored in red and in black the control sequences. Rectangular trees:
The transmission networks identified in PWID were further confirmed with Bayesian phylogenetic analyses. Molecular clock analyses were performed
separately for HCV genotypes 1a, 1b, 3a, 4a and 4d. Different clusters were specifically indicated on the trees. The posterior probability support and
tMRCA for each transmission cluster are represented at the internal nodes. The scale is in years.
https://doi.org/10.1371/journal.pone.0185866.g003
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For the majority of the patients this analysis suggested that HCV was introduced first, fol-
lowed by HIV. However, for 5 patients, HIV was introduced first; all of them were infected
with subtype F1 and genotype 3a or 4 HCV strains. Twenty three patients had ΔtMRCA
between HIV and HCV lineages of less than one year, suggesting potential co-transmission of
HIV and HCV. These 23 patients (19.65%) were present in the same HIV and HCV cluster
with at least one other patient, suggesting a potential simultaneous transmission (co-transmis-
sion) of both infections. We also found that such transmission events are largely associated
with particular HCV transmission clusters, specifically clusters c and l (Fig 5). Going back to
the records of these patients, we found that twenty-two of those 23 patients were in detention
at the moment of study enrolment. This population has a statistically significant higher proba-
bility of coincidental transmission (p<0.0001) when compared to the rest of the patients. Five
of these patients were infected with CRF14_BG and the rest with subtype F1; the infective
HCV genotypes were 1 or 4 (Fig 5).
Discussion
The PWID represent no more than an estimated 0.2–0.5% of the world’s population, but
they account for approximately 5–10% of all people living with HIV and 6.8% of the per-
sons infected with HCV [36, 37]. Since 2008 injected amphetamine type stimulants
(„legal highs”) became available on the market in Romania and were low-priced. As a
result, the number of PWID increased dramatically in recent years so that Romania
reported an HIV outbreak among PWID that started in 2011; more than 90% of PWID
being concentrated in Bucharest and its surroundings [10, 38]. Numerous people who
were injecting heroin have switched to the new class of drugs due to the lower price and
because they were legal at that time. An important behavioral characteristic is that the lat-
ter require up to 10 injections every day. This fact, which was coincident with an
Table 2. HCV and HIV transmission networks identified within Romanian PWID.
HCV genotype Cluster Number of PWID sequences within the cluster (%) Sampling period tMRCA (95% HPD)
Genotype 1a (N = 48) a 6 12.5 2013–2014 2008 (2006–2011)
b 5 10.42 2013–2014 1995 (1983–2002)
c 23 47.92 2013–2014 1987(1979–1995)
d 9 18.75 2013–2014 2004 (2001–2007)
Total 43 89.58
Genotype 1b (N = 40) e 9 22.50 2013–2014 1992 (1982–2002)
f 4 10.00 2013–2014 1983 (1968–1994)
g 13 32.5 2013–2014 2007 (2002–2010)
h 5 12.50 2013–2014 1989 (1979–1999)
Total 31 77.5
Genotype 3a (N = 14) i 4 28.57 2013–2014 2007 (2002–2011)
j 2 14.29 2013–2014 2011 (2007–2013)
k 3 21.43 2013–2014 2011 (2008–2013)
Total 9 64.28
Genotype 4a (N = 7) l 7 100 2013–2014 2010 (2007–2012)
Genotype 4d (N = 8) m 7 87.5 2013–2014 2011 (2007–2013)
HIV subtype
Subtype F1 (N = 79) 1 29 36.71 2013–2014 2006 (2001–2010)
2 44 55.70 2013–2014 2009 (2002–2010)
Total 73 92.40
CRF14_BG and recombinants (N = 30) 3 17 56.67 2013–2014 2007 (2004–2010)
https://doi.org/10.1371/journal.pone.0185866.t002
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interruption in needle exchange programs, greatly impacted the needle-sharing behavior
in the country [39]. Preliminary analyses indicated the circulation of CRF14_BG strains
in PWID, HIV strains associated with lower CD4 counts and X4 tropism at baseline, as
compared with the subtype F1 infected PWID [11, 40].
In this study we have identified, characterized and compared the viral transmission net-
works of HIV and HCV in a population of HIV-HCV co-infected PWID–using a group of
HCV mono-infected patients as controls—and we evaluated the time of introduction of
these viruses in this population and explored the probability of co-transmission of the two
infections.
The clinical and epidemiological impact of HIV-HCV co-infections in PWID has been
described by several studies [6, 41], but only one analysed in parallel the evolutionary history
of these two viruses within this particular risk population [35]. Viral genetic information
expressed as nucleotide sequences and analysed with phylogenetic and population genetics has
Fig 4. The most recent common ancestor (tMRCA) of HIV and HCV transmission clusters in PWID. The mean tMRCA and the
high posterior density interval (95%HPD) for each identified transmission cluster are plotted.
https://doi.org/10.1371/journal.pone.0185866.g004
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been shown to be very useful in identifying and characterizing transmission clusters of rapidly
evolving viruses such as HIV and HCV [42, 43].
Phylogenetic analysis performed in this study showed high levels of transmission network-
ing among Romanian PWIDs: three HIV clusters and thirteen HCV clusters have been identi-
fied. The majority of HIV strains fell in two F1 clusters that were nested within Romanian
reference strains. This suggests that F1 strains circulating for a long time among Romanian
patients, infected sexually and nosocomially were the origin of the subtype F1 outbreaks in
PWID and that these strains were restricted to Romania. The CRF14_BG strains circulating in
PWID are related with those described earlier in Spain and Portugal in the same risk group
population [11]. However, due to the limited number of CRF14_BG sequences available in
public databases, direct filiation between the two epidemiologic events cannot be ascertained.
Previous results indicated that the CRF14_BG sequences from Romanian PWID were closely
related with the Greek PWID sequences and formed a single monophyletic cluster. Molecular
clock analysis revealed that CRF14_BG strains circulating in PWID from Athens originated
from one or several strains circulating in Bucharest [12]. Our phylodynamic analyses indicated
that all HIV transmission networks originated at similar time points, dating back 7 to 10 years
ago, coincident with the availability of these new injectable amphetamine type stimulants on
the market. The patients infected with CRF14_BG had significantly lower CD4 counts at base-
line than those infected with F1 subtype strains despite the fact that phylogenetic and serocon-
version data suggest their being infected at similar time points. Although we have included in
our analysis all the PWID presented in our clinical settings during this period of time, the
number of patients infected with CRF14_BG recombinants was smaller than those infected
with subtype F1 and this might have impact on the statistical analysis. However, these data are
in agreement with previous studies showing an association between CRF14_BG infection,
CD4 T cells decline and disease severity, characterized by CXCR4 usage [11, 40, 44].
On the other hand, regardless of the HIV infecting strain, HCV viral loads were signifi-
cantly higher in co-infected PWID than in HCV mono-infected patients. This difference does
not seem to be related to the HCV genotype. Moreover, when comparing HCV mono-infected
patients with co-infected PWID carrying HCV genotype 1b, the difference in viral load contin-
ued to be statistically significant (S1 Fig). Several studies have shown an accelerated disease
progression in HIV-HCV co-infected patients, HIV infection increasing the HCV replication,
hepatic inflammation and impairing HCV-specific immune response [6]. Since CRF14_BG
induced a massive depletion of CD4 T cells it was expected to be associated with impaired
HCV immune control and thus higher replication and hepatic fibrosis. However, no signifi-
cant difference in HCV VL was observed between CRF14_BG and subtype F1 infected patients
or between HCV VL and CD4 count. Possibly, longer infection periods could be needed to
impair the established HCV-specific immune response, since in most of the cases, HCV infec-
tion preceded HIV infection.
Previous studies have shown the genotype 1b to be mainly acquired through blood transfu-
sion, while genotypes 1a and 3a are associated with intravenous drug use [45]. In other Euro-
pean countries, mostly HCV genotype 4 has been identified in PWID: subtype 4a in Greece,
4d in Italy and The Netherlands and 4c and 4d in Spain were linked to drug usage [46–49].
Our results indicate the circulation of multiple HCV genotypes in co-infected Romanian
PWID: 1a, 1b, 3a, 4a and 4d. However, only HCV genotype 1b was found in the HCV mono-
Fig 5. Transmission dynamics of HIV and HCV infections. The comparative analysis of the clustering patterns in
HIV-HCV co-infected patients is presented. The number of all sequences that were part of both HIV and HCV clusters are
shown, in brackets being the simultaneous transmission cases; sequences with a difference of mean divergence times
between HCV and HIV (ΔtMRCA) <1.
https://doi.org/10.1371/journal.pone.0185866.g005
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infected group, indicating a higher complexity of the HCV epidemic among co-infected
PWID.
According to phylodynamic analyses, HCV genotype 1b was the first to be introduced in
Romania, followed by genotype 1a. The oldest 1b cluster was estimated to be 30 years old in
PWID and more than 50 years in non-PWID. Previous studies indicated that the circulation of
this genotype in Romania was almost exclusive for a long period of time [50, 51]. Genotypes 3
and 4 are much more recent and linked to intravenous drug usage; with an estimated origin
around 10 years ago, they might also be linked to the availability of injected amphetamine type
stimulants [52].
The differences in transmission clustering between HCV and HIV might be explained
in part by their estimated acquisition time. Previous observations based on classical epidemio-
logical data indicated that HCV was introduced in PWID much earlier, being associated with
heroin use while HIV infection is linked with new psychoactive drugs [11]. Phylodynamic
analysis presented in this study sustains this observation, showing that HIV strains were intro-
duced in PWID in recent years whereas HCV genotypes 1a and 1b had been circulating several
decades before. However, HCV transmission networks of genotypes 3 and 4 apparently started
later, as they were dated as very recent (2010–2011), thus indicating a potential linkage of these
genotypes with new psychoactive drugs.
When comparing the transmission chains of HIV and HCV, we evaluated both the congru-
ence between HIV and HCV transmission chains, as well as the likelihood of simultaneous
transmission of both infections. We found that most patients (68.4%) were present both in
HIV and HCV transmission clusters and that for the majority of the patients’ transmission of
HIV and HCV occurred through (at least partly) overlapping transmission chains (Fig 5). We
used the method reported by Ng TK and collaborators [35] to evaluate the frequency of viral
coincidental transmission. Applying this method to Romanian co-infected PWID, we found
that, for most of the patients, and in accordance with epidemiological data, HCV infection was
acquired before HIV.
Nevertheless, we identified 23 cases of possible co-transmission (19.65%), corresponding to
patients with ΔtMRCA<1 and clustering in partly overlapping transmission chains. Interest-
ingly, these transmission events were associated with particular clusters of genotype 1a and 4a.
Further investigation lead us to the finding that 22 of these 23 patients were in detention in the
same penitentiary. While largely overlapping transmission chains would be expected, given
the fact that this population forcely shares the same contact network while in detention, a
higher likelihood of simultaneous transmission of the infections is not necessarily expected in
this context. Therefore, our findings call for further investigation about what type of behavioral
patterns explain the high rate of co-transmission of HIV and HCV in this penitentiary when
compared to the rest of the PWID population. One potential bias in our analysis could be the
subevaluation of possible super-infections and co-transmissions: phylogenetic analysis based
on population sequencing considers only the predominant viral infective strain. Coincidental
transmissions could be underestimated in our analysis if the transmitted strains did not
become visible within the viral population.
The HIV epidemic among Romanian PWID continues to represent a major problem and
HCV co-infection contributes to the worse prognostic within this specific risk population.
This study clarifies and compares the patterns of spread and transmission of these two viruses
in Romanian PWID, suggesting that a higher rate of transmission of HIV rather than HCV is
associated with behavioral changes mainly following the availability of new types of injected
drugs (‘legal highs’). While overlapping of HIV and HCV transmission chains is common, the
estimated transmission of both viruses within a short time span is less common, with a rate of
only 19.65% in this population, and largely associated with drug injection within the same
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penitentiary. Our results illustrate the need for better prevention policies in the PWID popula-
tion, in particular and more urgently in the prison population, where an outbreak of simulta-
neous HIV and HCV transmissions seems to be occurring.
One limitation of the study is that the inmate population is overrepresented in the PWID so
that extrapolation to the general population should be cautious. It should be though noted
that, within this rather small group, no significant clinical or epidemiologic differences were
noted according to the inprison vs. outprison status.
Accession numbers
86 HIV nucleotide sequences reported in this paper were newly deposited in GenBank and
have the following accession numbers: KX158994—KX159079. The remaining 31 HIV
sequences were previously published in Genbank [11] and have the following accession num-
bers: KJ194665, KJ194822, KJ194819, KJ194811, KJ194662, KJ194666, KJ194821, KJ194824,
KJ194733, KJ194816, KJ194818, KJ194826, KJ194668, KJ194817, KJ194823, KJ194669,
KJ194808, KJ194664, KJ194663, KJ194810, KJ194820, KJ194813, KJ194809, KJ194828,
KJ194807, KJ194806, KJ194827, KJ194815, KJ194825, KJ194805, KJ194672.
HCV nucleotide sequences used in this analysis were recently deposited in Genbank.
HCV-NS5b sequences were deposited with the following accession numbers: KX158877—
KX158993. Accession numbers for HCV–NS3 nucleotide sequences corresponding to
PWID are: KX159080—KX159189 and for the monoinfected patients (control group) are:
KX159190—KX159224.
Supporting information
S1 Fig. HCV viral load (VL) comparison between HCV monoinfected and co-infected
patients with genotype 1b. Statistical analysis was performed with Mann-Whitney test, p
value < 0.05 was considered significant.
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